Treatment of scabies using a tea tree oil-based gel formulation in Australian Aboriginal children: protocol for a randomised controlled trial
Open Access
Abstract
Introduction In remote Aboriginal communities in Australia, scabies affects 7 out of 10 children before their first birthday. This is more than six times the rate seen in the rest of the developed world. Scabies infestation is frequently complicated by bacterial infection, leading to the development of skin sores and other more serious consequences, such as septicaemia and chronic heart and kidney diseases. Tea tree oil (TTO) has been used as an antimicrobial agent for several decades with proven clinical efficacy. Preclinical investigations have demonstrated superior scabicidal properties of TTO compared with widely used scabicidal agents, such as permethrin 5% cream and ivermectin. However, current data are insufficient to warrant a broad recommendation for its use for the management of scabies because previous studies were small or limited to in vitro observations. Methods and analysis A pragmatic first trial will examine the clinical efficacy of a simple and low-cost TTO treatment against paediatric scabies and the prevention of associated secondary bacterial infections, with 1:1 randomisation of 200 participants (Aboriginal children, aged 5–16 years and living in remote Australia) into active control (permethrin 5% cream) and treatment (5% TTO gel) groups. The primary outcome for the study is clinical cure (complete resolution). Secondary outcome measures will include relief of symptoms, recurrence rate, adverse effects, adherence to treatment regimen and patient acceptability. Ethics and dissemination The project has received approvals from the University of Canberra Human Research Ethics Committee (HREC 16-133), Wurli-Wurlinjang Health Service Indigenous subcommittee and the Aboriginal Medical Services Alliance Northern Territory reference group. The results of this study will be published in core scientific publications, with extensive knowledge exchange activities with non-academic audiences throughout the duration of the project. Trial registration ACTRN12617000902392; Pre-results.Keywords
Funding Information
- University of Canberra
This publication has 37 references indexed in Scilit:
- A Novel Clinical Grading Scale to Guide the Management of Crusted ScabiesPLOS Neglected Tropical Diseases, 2013
- Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis-infected pediatric patients: A single blind, randomized controlled trialJournal of Pharmacology and Pharmacotherapeutics, 2013
- Activity of tea tree oil and nerolidol alone or in combination against Pediculus capitis (head lice) and its eggsParasitology Research, 2012
- Complement Inhibitors from Scabies Mites Promote Streptococcal Growth – A Novel Mechanism in Infected Epidermis?PLOS Neglected Tropical Diseases, 2012
- Sarcoptes scabieivar.canisrefractory to ivermectin treatment in two dogsVeterinary Dermatology, 2010
- Scabies in healthcare settingsCurrent Opinion in Infectious Diseases, 2010
- Scabies and pyodermas - diagnosis and treatmentDermatologic Therapy, 2009
- The Economic Burden of Pediculosis Pubis and Scabies Infections Treated on an Outpatient Basis in the United States: Evidence From Private Insurance Claims Data, 2001–2005Sexually Transmitted Diseases, 2009
- Effects of Different Plant Products against Pig Mange MitesActa Veterinaria Brno, 2006
- Predictive Testing for Irritancy and Allergenicity of Tea Tree Oil in Normal Human SubjectsExogenous Dermatology, 2003